Orchestra BioMed, Inc., on Sept. 4 announced it received CE mark approval for its Moderato implantable pulse generation system, which delivers the company’s trademarked cardiac neuromodulation therapy to patients while simultaneously acting as a pacemaker.

Continuous at-home monitoring with smart device-based photoplethysmography technology could be a viable strategy for AFib screening and early detection, according to a population-level study out of China.

A study of more than 181,000 patients at the Mayo Clinic has proven the efficacy of an AI algorithm in spotting AFib on seemingly normal EKGs, the Daily Mail reports.

A combination of 107 chest compressions per minute at a depth of 4.7 centimeters is the optimal CCR-CCD (chest compression rate-chest compression depth) ratio for survival after an out-of-hospital cardiac arrest, researchers reported August 14 in JAMA Cardiology.

Non-selective His bundle pacing is noninferior to selective HBP in patients undergoing de novo permanent pacemaker implantation for bradycardia, according to a study that revealed similar outcomes for death and HF between the two therapies.

The odds a heart patient will experience complications after they’re implanted with a cardiac device vary depending on where they receive care, according to work published in the Annals of Internal Medicine July 30.

Sixty-nine people have survived out-of-hospital cardiac arrests at Hawaii’s airports since an AED program was first implemented in 2006, the Oregonian reports.

Medications used to treat atrial fibrillation—namely amiodarone—could increase older patients’ risk of fainting and falling, Danish researchers have found.